| 000 | 01840 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516095851.0 | ||
| 264 | 0 | _c20121217 | |
| 008 | 201212s 0 0 eng d | ||
| 022 | _a1879-0712 | ||
| 024 | 7 |
_a10.1016/j.ejphar.2012.06.015 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHiratochi, Masahiro | |
| 245 | 0 | 0 |
_aHypouricemic effects of novel concentrative nucleoside transporter 2 inhibitors through suppressing intestinal absorption of purine nucleosides. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmacology _cSep 2012 |
||
| 300 |
_a183-91 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBiological Transport _xdrug effects |
| 650 | 0 | 4 | _aCOS Cells |
| 650 | 0 | 4 | _aCebus |
| 650 | 0 | 4 | _aChlorocebus aethiops |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aFurans _xchemistry |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 | _aHeLa Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInosine _xmetabolism |
| 650 | 0 | 4 |
_aIntestinal Absorption _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMembrane Transport Proteins _xmetabolism |
| 650 | 0 | 4 |
_aPurine Nucleosides _xmetabolism |
| 650 | 0 | 4 |
_aRNA, Fungal _xadministration & dosage |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aRenal Tubular Transport, Inborn Errors _xblood |
| 650 | 0 | 4 |
_aUric Acid _xblood |
| 650 | 0 | 4 |
_aUrinary Calculi _xblood |
| 700 | 1 | _aTatani, Kazuya | |
| 700 | 1 | _aShimizu, Kazuo | |
| 700 | 1 | _aKuramochi, Yu | |
| 700 | 1 | _aKikuchi, Norihiko | |
| 700 | 1 | _aKamada, Noboru | |
| 700 | 1 | _aItoh, Fumiaki | |
| 700 | 1 | _aIsaji, Masayuki | |
| 773 | 0 |
_tEuropean journal of pharmacology _gvol. 690 _gno. 1-3 _gp. 183-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejphar.2012.06.015 _zAvailable from publisher's website |
| 999 |
_c21874823 _d21874823 |
||